167 related articles for article (PubMed ID: 37900961)
1. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma.
Li XM; Liu SP; Liu DM; Li Y; Cai XM; Su Y; Xie ZF
Open Med (Wars); 2023; 18(1):20230825. PubMed ID: 37900961
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma.
Li Y; Chen MX; Li HT; Cai XM; Chen B; Xie ZF
Open Med (Wars); 2024; 19(1):20240906. PubMed ID: 38463521
[TBL] [Abstract][Full Text] [Related]
3. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
Zhou Y; Cao Y; Liu W; Wang L; Kuang Y; Zhou Y; Chen Q; Cheng Z; Huang H; Zhang W; Jiang X; Wang B; Ren C
Front Immunol; 2023; 14():1294459. PubMed ID: 38162649
[TBL] [Abstract][Full Text] [Related]
4. Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma.
Li XM; Liu SP; Li Y; Cai XM; Zhang SB; Xie ZF
Heliyon; 2023 Aug; 9(8):e18436. PubMed ID: 37520990
[TBL] [Abstract][Full Text] [Related]
5. Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn's Disease.
Fu M; Aihemaiti D; Fu H; Li N; Yuan Y; Ye M
J Inflamm Res; 2024; 17():3655-3670. PubMed ID: 38863903
[TBL] [Abstract][Full Text] [Related]
6. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
7. Identification of disulfidptosis-related genes and analysis of immune infiltration characteristics in ischemic strokes.
Qin R; Huang L; Xu W; Qin Q; Liang X; Lai X; Huang X; Xie M; Chen L
Math Biosci Eng; 2023 Oct; 20(10):18939-18959. PubMed ID: 38052584
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease.
Yu X; Guo Z; Fang Z; Yang K; Liu C; Dong Z; Liu C
Front Genet; 2023; 14():1251999. PubMed ID: 37745847
[No Abstract] [Full Text] [Related]
9. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma.
Li W; Ling L; Xiang L; Ding P; Yue W
Front Cell Neurosci; 2023; 17():1146686. PubMed ID: 36925967
[TBL] [Abstract][Full Text] [Related]
11. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
12. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
Mou Y; Zhang L; Liu Z; Song X
BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
[TBL] [Abstract][Full Text] [Related]
13. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients.
Wang X; Yang J; Yang F; Mu K
Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease.
Luo X; Guo J; Deng H; He Z; Wen Y; Si Z; Li J
Front Immunol; 2024; 15():1386905. PubMed ID: 38812509
[TBL] [Abstract][Full Text] [Related]
16. Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer's disease molecular subtypes.
Zhu Y; Kong L; Han T; Yan Q; Liu J
Immun Inflamm Dis; 2023 Oct; 11(10):e1037. PubMed ID: 37904698
[TBL] [Abstract][Full Text] [Related]
17. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
18. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning.
Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D
Front Genet; 2023; 14():1193944. PubMed ID: 37456667
[No Abstract] [Full Text] [Related]
19. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
20. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
